Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic SyndromesElisabetta Sauta, Matteo Giovanni Della Porta, Matteo Zampini et al.|Blood|2022Cited by 4
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)Luca Lanino, Vladan Vučinić, Yu‐Hung Wang et al.|Blood|2024Cited by 3
Synthetic Histopathological Images Generation with Artificial Intelligence to Accelerate Research and Improve Clinical Outcomes in HematologyGianluca Asti, Matteo Giovanni Della Porta, Saverio D’Amico et al.|Blood|2023Cited by 2
Enhancing Personalized Prognostic Assessment of Myelodysplastic Syndromes through a Multimodal and Explainable Deep Data Fusion Approach (MAGAERA)Elisabetta Sauta, Matteo Giovanni Della Porta, Elena Riva et al.|Blood|2024Cited by 2
Molecular Classification of Chronic Myelomonocytic Leukemia: Results of the Analysis of an International Cohort of 2,471 PatientsLuca Lanino, Rami S. Komrokji, Raphaël Itzykson et al.|Blood|2023Cited by 1